Spectrum of Kidney Involvement in Sickle Cell Disease: A Systematic Review and Meta‐Analysis
International Journal of Clinical Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ijcp/5170253 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Clinical Practice, online erschienen am 13.08.2026. Verfasst von Ibrahim Anyass Goumboundi und 11 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sickle cell disease (SCD) is associated with progressive renal complications collectively termed sickle cell nephropathy, which significantly contribute to morbidity and mortality. However, the burden and distribution of renal manifestations across disease stages remain inconsistently reported.
Objective
This study aimed to systematically review and meta‐analyze the prevalence of renal involvement in individuals with SCD, including albuminuria (reported as microalbuminuria and macroalbuminuria in some studies), proteinuria, and chronic kidney disease (CKD) and to explore genotype‐ and age‐group‐specific differences.
Methods
A systematic review and meta‐analysis were conducted in accordance with PRISMA guidelines. PubMed, Scopus, and Google Scholar were searched from 2015 to 2026. Observational studies reporting prevalence data on renal outcomes in SCD were included. Pooled prevalence estimates were calculated using a random‐effects model with Freeman–Tukey transformation. Heterogeneity was assessed using the I 2 statistic, and subgroup analyses were performed based on genotype and age group.
Results
A total of thirty‐eight (38) studies were included. The pooled prevalence of albuminuria was 34% (95% CI: 27%–41%; I 2 = 93.2%). Among hemoglobin SS (HbSS) patients, albuminuria prevalence was higher at 39% (95% CI: 29%–49%; I 2 = 93.9%) and 22% (95% CI: 1%–56%; I 2 = 68.7%) among hemoglobin SC (HbSC) patients. The pooled prevalence of CKD was 43% (95% CI: 26%–61%; I 2 = 99.2%), increasing to 65% (95% CI: 35%–89%; I 2 = 96.8%) in HbSS individuals. Microalbuminuria was the most frequently reported manifestation (29%), followed by proteinuria (18%) and macroalbuminuria (11%). Age‐stratified analysis showed lower albuminuria prevalence in children (23%) compared to adults (48%), suggesting an increasing burden of renal abnormalities with age.
Conclusion
Renal complications are highly prevalent in SCD, with albuminuria representing an early marker of kidney injury and CKD reflecting advanced disease. The higher burden observed in HbSS patients and adults underscores the progressive nature of sickle cell nephropathy. Early detection and routine monitoring are essential to mitigate progression and improve long‐term outcomes.
Zitieren
APA
Goumboundi, I. A., Afrifa, J., Okyere, P., Rashid, M., Larnyoh, M. T., Siame, D., Yevugah, F., Nartey, G. N., Ayettey, E. N. A., Kwarteng, P. O., Aderoju, Y. B. G., & Ephraim, R. K. D. (2026). Spectrum of Kidney Involvement in Sickle Cell Disease: A Systematic Review and Meta‐Analysis. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/5170253
Vancouver
Goumboundi IA, Afrifa J, Okyere P, Rashid M, Larnyoh MT, Siame D, et al. Spectrum of Kidney Involvement in Sickle Cell Disease: A Systematic Review and Meta‐Analysis. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/5170253
BibTeX
@article{Goumboundi2026,
author = {Goumboundi, Ibrahim Anyass and Afrifa, Justice and Okyere, Perditer and Rashid, Manahil and Larnyoh, Moses Tetteh and Siame, Dion and Yevugah, Fafali and Nartey, Gloria N. and Ayettey, Eugenia N. A. and Kwarteng, Philip Obeng and Aderoju, Yaa Boahemaa Gyasi and Ephraim, Richard K. D.},
title = {Spectrum of Kidney Involvement in Sickle Cell Disease: A Systematic Review and Meta‐Analysis},
journal = {International Journal of Clinical Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijcp/5170253}
}
EUVIMED